Skip to main navigationSkip to main content
The University of Southampton
Medicine
Phone:
01722 425048
Email:
D.J.G.Mackay@soton.ac.uk

Professor Deborah Mackay MA, PhD

Professor of Medical Epigenetics

Professor Deborah Mackay's photo
Related links

Professor Deborah Mackay is Professor of Medical Epigenetics within Medicine at the University of Southampton. She is the laboratory lead of the Wessex Imprinting Group, a translational research group investigating the molecular basis and clinical impact of human imprinting disorders. The group works at the interface of clinical care, diagnosis and research and has unique potential to translate novel research findings into clinical benefit.

Epigenetics is development written on the genome. For me, medical epigenetics is understanding how this writing works, and what happens to the individual when it goes wrong

Deborah studied Biochemistry at the University of Oxford, took her PhD in cell biology at ICRF, and began her postdoctoral work as a molecular cell biologist at UCL before developing her current interests in human medical genetics and epigenetics.

Qualifications

MA, Biochemistry, University of Oxford (1989)

PhD, University of London (1993)

Appointments held

Lecturer, University of Southampton (2007)

Reader, University of Southampton (2012)

 

 

Research interests

Research:

Deborah Mackay leads the Wessex Imprinting Group in a broad programme of research on human imprinting disorders, which are congenital disorders affecting the regulation of genes rather than their DNA sequence. Her group is delineating the genetic causes, epigenetic features and clinical consequences of imprinting disorders, with two aims: to understand the biology of imprinting, and to improve the lives of patients affected by these disorders.

Imprinting disorders

The group identified the locus for the rare imprinting disorder transient neonatal diabetes (TND, characterised by severe growth restriction and infant diabetes), defined the DNA methylation anomaly that causes it, and developed robust testing for the disorder in affected neonates. In recent years she has studied further syndromes, including the overgrowth disorder Beckwith-Wiedemann syndrome (BWS), the growth restriction disorders Silver-Russell Syndrome (SRS) and Temple Syndrome (TS14), and the metabolic disorder Pseudohypoparathyroidism type 1b (PHP1b). Moreover, her group identified the archetypal ‘multi-locus imprinting disorder’ (MLID) in patients with DNA methylation problems affecting multiple imprinted genes throughout the genome. This has led to a fundamental redevelopment of the way we think about evolution of the epigenome in development. The group has developed informatic tools to delineate MLID in order to stratify patients and better understand the mechanisms and consequence of disease.

Genetic causes of Imprinting disorders

Dr Mackay’s group showed that mutations in ZFP57 are associated with a multi-locus methylation disorder, implicating ZFP57 in regulation of imprinting during early development. More recently the group has identified genetic changes in the mothers of individuals with MLID, which are associated with a wide range of reproductive outcomes in offspring. This work has suggested critical connections between epigenetic marks, maternal reproductive fitness and offspring development and health.

IDFOW

The research project “Imprinting disorders – finding out why” (IDFOW) is a pilot survey of DNA methylation anomalies in a UK-based patient cohort. With recruitment running at ~100 per year the study is showing that imprinting disorders are more common and more diverse than currently suspected.  Her work supports genotype-phenotype correlation, improved diagnosis, and personalised clinical management. The group is also seeking novel genetic causes to help the families in IDFOW. Cis- and trans-acting DNA mutations and rearrangements have been found that disrupt epigenetic control of gene expression, causing growth and developmental anomalies; they are deploying exome and genome sequencing, as well as new next-generation sequencing approaches for epigenetics, to interpret these changes.

 

 

Department(s)

Human Development and Health

Affiliate Department(s)

Human Development and Physiology

2015- Programme lead, MSc Genomic Medicine

Postgraduate student supervision

2007-10 - Claire Turner MD

2010-13 - Emma Baple PhD

2013-15 – Olumakemi Lokulo-Sodipe PhD

 

Sort via:TypeorYear

Articles

Book Chapter

  • Temple, I., & Mackay, D. (2018). Diabetes mellitus, 6q24=related transient neonatal. In M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J. H. Bean, K. Stephens, & A. Amemiya (Eds.), GeneReviews [Internet] (GeneReviews). Washington: University of Washington.

Letters/Editorials

Reviews

Professor Deborah Mackay
Professor of Medical Epigenetics Wessex Regional Genetics Laboratory Salisbury District Hospital Salisbury Wilts SO2 8BJ Tel: 01722 429080 (Main office) or 01722 425048 (direct) Fax: 01722 331531

Room Number: WRGL

Telephone:01722 425048
Email:D.J.G.Mackay@soton.ac.uk

Share this profile Share this on Facebook Share this on Twitter Share this on Weibo

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×